After a decades-long drought, study of the therapeutic potential of psychedelics is booming again thanks to the collective efforts of organizations and research teams worldwide. Thousands of studies have been conducted since the 1950s – the current psychedelic renaissance is backed by over 50 years of science and data.
As research continues & more data becomes available, we will deepen our understanding of the impact that psychedelics have in reducing the economic and health burden of mental health disorders.
Psilocybin with Psychological Support for Treatment-Resistant Depression: An Open-Label Feasibility Study
Study provides preliminary support for the safety and efficacy of psilocybin for treatment-resistant depression.
Psilocybin Produces Substantial & Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer
Study finds that high-dose psilocybin produced large decreases in measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.
A Recent Clinical Trial Examined This Important Question: Is Psilocybin-Assisted Therapy Efficacious Among Patients With Major Depressive Disorder?